Global maternal mortality has fallen significantly over the past 30 years, yet the pace of improvement has slowed in recent years and gains remain deeply uneven across nations, according to new research from the Global Burden of Disease (GBD) 2023 study published in The Lancet Obstetrics, Gynaecology, & Women's Health. The large-scale observational analysis found that while 2023 data reflect meaningful long-term progress, more than 100 countries continue to fall short of internationally established maternal mortality reduction targets. The GBD study is one of the most comprehensive systematic analyses of global health metrics, drawing on data from hundreds of sources across countries; however, as an observational study, it cannot establish causality between specific interventions and mortality outcomes. Readers should note that GBD analyses rely partly on modeled estimates in regions with limited civil registration data, which introduces uncertainty, particularly in sub-Saharan Africa and parts of South Asia where maternal death burdens are highest. No conflicts of interest specific to this summary were identified, though GBD research receives funding from the Bill & Melinda Gates Foundation, a detail relevant to transparency. The findings underscore persistent structural gaps in access to skilled birth attendants, emergency obstetric care, and postpartum services in lower-income settings. The slowdown in recent progress raises concerns about achieving Sustainable Development Goal 3.1, which targets a global maternal mortality ratio below 70 per 100,000 live births by 2030. Source: https://medicalxpress.com/news/2026-03-global-maternal-deaths-fell-countries.html